GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT Trademark

Trademark Overview


On Thursday, October 26, 2017, a trademark application was filed for GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT with the United States Patent and Trademark Office. The USPTO has given the GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT trademark a serial number of 87660522. The federal status of this trademark filing is REGISTERED as of Tuesday, June 22, 2021. This trademark is owned by Genesis Drug Discovery & Development, LLC. The GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery
gd3 genesis drug discovery & development

General Information


Serial Number87660522
Word MarkGD3 GENESIS DRUG DISCOVERY & DEVELOPMENT
Filing DateThursday, October 26, 2017
Status700 - REGISTERED
Status DateTuesday, June 22, 2021
Registration Number6396881
Registration DateTuesday, June 22, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements


Description of MarkThe mark consists of the wording "GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT" and a design. The letters "G" and "D" are depicted inside a bisected oblong shape representing a pill. The letter "G" is in white with an outline in various shades of red. The letter "D" is in white with an outline in various shades of grey. The left half of the pill design with the letter "G" is in various shades of red. The right side of the pill design with the letter "D" is in various shades of grey. The number "3" is depicted in red with a white outline inside a stylized depiction of a molecule located to the upper right of the "GD" lettering. The molecule consists of four gold spheres representing atoms, which are connected by three straight bands in various shades of grey representing bonds. The stylized wording "GENESIS" appears in red below the "GD" lettering and pill design. The stylized wording "DRUG DISCOVERY & DEVELOPMENT" appears in smaller black font below the wording "GENESIS".
Pseudo MarkGD THREE GENESIS DRUG DISCOVERY AND DEVELOPMENT
Indication of Colors claimedThe color(s) red, black, white, gray and gold is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"DRUG DISCOVERY & DEVELOPMENT"
Goods and ServicesScientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 4, 2017
Primary Code042
First Use Anywhere DateWednesday, November 30, 2016
First Use In Commerce DateWednesday, November 30, 2016

Trademark Owner History


Party NameGenesis Drug Discovery & Development, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Party NameGenesis Drug Discovery & Development, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Party NameGenesis Drug Discovery & Development, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events


Event DateEvent Description
Friday, September 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 22, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 18, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 17, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 30, 2021ASSIGNED TO EXAMINER
Wednesday, April 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 2, 2020NON-FINAL ACTION E-MAILED
Monday, November 2, 2020SU - NON-FINAL ACTION - WRITTEN
Saturday, October 31, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, October 16, 2020USE AMENDMENT FILED
Saturday, October 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 16, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 3, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 1, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, November 1, 2019FINAL REFUSAL E-MAILED
Friday, November 1, 2019FINAL REFUSAL WRITTEN
Thursday, October 10, 2019SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, March 28, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 26, 2019ASSIGNED TO LIE
Thursday, September 6, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 6, 2018LETTER OF SUSPENSION E-MAILED
Thursday, September 6, 2018SUSPENSION LETTER WRITTEN
Saturday, August 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 21, 2018NON-FINAL ACTION E-MAILED
Wednesday, February 21, 2018NON-FINAL ACTION WRITTEN
Tuesday, February 6, 2018ASSIGNED TO EXAMINER
Tuesday, November 7, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, November 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 30, 2017NEW APPLICATION ENTERED